Wellington Management Group LLP Acquires 2,116 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Wellington Management Group LLP grew its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 34.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,189 shares of the medical device company’s stock after purchasing an additional 2,116 shares during the period. Wellington Management Group LLP’s holdings in Cooper Companies were worth $3,099,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the stock. Lipe & Dalton grew its stake in Cooper Companies by 0.9% during the fourth quarter. Lipe & Dalton now owns 3,360 shares of the medical device company’s stock worth $1,272,000 after buying an additional 30 shares during the last quarter. WD Rutherford LLC increased its holdings in Cooper Companies by 0.4% during the 4th quarter. WD Rutherford LLC now owns 9,126 shares of the medical device company’s stock valued at $3,541,000 after purchasing an additional 33 shares in the last quarter. Blue Trust Inc. raised its position in Cooper Companies by 54.8% in the 4th quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 34 shares during the last quarter. Franklin Resources Inc. boosted its stake in Cooper Companies by 1.2% in the fourth quarter. Franklin Resources Inc. now owns 3,401 shares of the medical device company’s stock worth $1,287,000 after purchasing an additional 41 shares in the last quarter. Finally, Venturi Wealth Management LLC grew its holdings in shares of Cooper Companies by 30.4% during the fourth quarter. Venturi Wealth Management LLC now owns 180 shares of the medical device company’s stock worth $68,000 after purchasing an additional 42 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

COO has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. Citigroup upped their target price on shares of Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. JPMorgan Chase & Co. upgraded shares of Cooper Companies from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $100.00 to $120.00 in a research report on Wednesday, March 13th. Robert W. Baird increased their price objective on Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research report on Friday, May 31st. Finally, Redburn Atlantic upgraded Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 target price for the company in a research report on Tuesday, March 19th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus target price of $111.42.

Cooper Companies Trading Down 0.4 %

NASDAQ COO opened at $87.30 on Monday. The Cooper Companies, Inc. has a 12 month low of $75.93 and a 12 month high of $104.07. The stock has a 50-day simple moving average of $92.73 and a 200 day simple moving average of $94.84. The company has a current ratio of 1.95, a quick ratio of 1.14 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $17.38 billion, a PE ratio of 51.28, a P/E/G ratio of 2.16 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The company had revenue of $942.60 million during the quarter, compared to analysts’ expectations of $948.07 million. During the same period in the prior year, the business posted $0.77 EPS. Cooper Companies’s revenue was up 7.4% on a year-over-year basis. Research analysts forecast that The Cooper Companies, Inc. will post 3.57 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.